Clarity Pharmaceuticals Ltd (CU6.AX)
AUD 1.83
(4.87%)
AUD 1.83
(4.87%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 11.5 Million AUD | 18.62% |
| 2023 | 9.7 Million AUD | 51.26% |
| 2022 | 6.41 Million AUD | 101.6% |
| 2021 | 3.18 Million AUD | 14.76% |
| 2020 | 2.77 Million AUD | 5.73% |
| 2019 | 2.62 Million AUD | 7.58% |
| 2018 | 2.43 Million AUD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.7 Million AUD | 36.76% |
| 2024 Q3 | 3.04 Million AUD | 14.53% |
| 2024 FY | -153.06 Thousand AUD | -101.58% |
| 2024 Q2 | 2.65 Million AUD | -1.89% |
| 2024 Q4 | 2.94 Million AUD | 0.0% |
| 2023 Q4 | 1.98 Million AUD | -2.61% |
| 2023 FY | 9.7 Million AUD | 51.26% |
| 2023 Q3 | 2.03 Million AUD | -27.84% |
| 2023 Q2 | 2.81 Million AUD | -1.66% |
| 2023 Q1 | 2.86 Million AUD | 59.94% |
| 2022 Q1 | 1.4 Million AUD | 52.0% |
| 2022 FY | 6.41 Million AUD | 101.6% |
| 2022 Q4 | 1.79 Million AUD | -1.85% |
| 2022 Q3 | 1.82 Million AUD | 31.25% |
| 2022 Q2 | 1.39 Million AUD | -0.89% |
| 2021 FY | 3.18 Million AUD | 14.76% |
| 2021 Q1 | 665.87 Thousand AUD | -14.82% |
| 2021 Q4 | 923.47 Thousand AUD | -0.95% |
| 2021 Q2 | 658.87 Thousand AUD | -1.05% |
| 2021 Q3 | 932.35 Thousand AUD | 41.51% |
| 2020 Q1 | 604.81 Thousand AUD | 0.0% |
| 2020 Q2 | 595.81 Thousand AUD | -1.49% |
| 2020 Q4 | 781.76 Thousand AUD | -0.99% |
| 2020 Q3 | 789.59 Thousand AUD | 32.52% |
| 2020 FY | 2.77 Million AUD | 5.73% |
| 2019 FY | 2.62 Million AUD | 7.58% |
| 2018 FY | 2.43 Million AUD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| AdAlta Limited | 1.5 Million AUD | -663.084% |
| Acrux Limited | -1.28 Million AUD | 996.158% |
| Botanix Pharmaceuticals Limited | -6.55 Million AUD | 275.633% |
| BTC Health Limited | 16.36 Thousand AUD | -70234.138% |
| Chimeric Therapeutics Limited | 7.45 Million AUD | -54.374% |
| Clinuvel Pharmaceuticals Limited | 78.09 Million AUD | 85.266% |
| Biome Australia Limited | 7.66 Million AUD | -50.028% |
| Hexima Limited | - AUD | -Infinity% |
| Immutep Limited | 1.44 Million AUD | -696.913% |
| Memphasys Limited | 1606.00 AUD | -716379.763% |
| Neuren Pharmaceuticals Limited | 205.17 Million AUD | 94.392% |
| Noxopharm Limited | -534.81 Thousand AUD | 2251.539% |
| Prescient Therapeutics Limited | 3.71 Million AUD | -209.955% |
| Race Oncology Limited | 1.38 Million AUD | -727.868% |
| Radiopharm Theranostics Limited | -21.3 Million AUD | 154.001% |
| Starpharma Holdings Limited | 7.65 Million AUD | -50.276% |
| Tissue Repair Ltd | 150.51 Thousand AUD | -7545.066% |
| Biotron Limited | -40.49 Thousand AUD | 28512.922% |
| Alterity Therapeutics Limited | 3.8 Million AUD | -202.411% |
| CSL Limited | 15.28 Billion AUD | 99.925% |
| EZZ Life Science Holdings Limited | 50.94 Million AUD | 77.414% |
| Anatara Lifesciences Ltd | -748.91 Thousand AUD | 1636.455% |
| Bio-Gene Technology Limited | -301.44 Thousand AUD | 3917.118% |
| Zelira Therapeutics Limited | 10.28 Thousand AUD | -111789.002% |
| Patrys Limited | 1.39 Million AUD | -725.346% |
| Orthocell Limited | 3.68 Million AUD | -211.967% |
| Imugene Limited | -5.83 Million AUD | 297.037% |
| PYC Therapeutics Limited | 22.05 Million AUD | 47.838% |
| Proteomics International Laboratories Limited | -1.12 Million AUD | 1124.464% |
| Cynata Therapeutics Limited | 2.31 Million AUD | -396.91% |
| Arovella Therapeutics Limited | -25.97 Thousand AUD | 44392.178% |
| Nanollose Limited | -348.95 Thousand AUD | 3397.492% |
| Invex Therapeutics Ltd | 1.21 Million AUD | -849.194% |
| NeuroScientific Biopharmaceuticals Limited | -91.33 Thousand AUD | 12698.033% |
| Amplia Therapeutics Limited | 4.01 Million AUD | -186.895% |
| Island Pharmaceuticals Limited | 1.25 Million AUD | -819.375% |
| Nyrada Inc. | -5164.07 AUD | 222921.631% |
| Telix Pharmaceuticals Limited | 308.5 Million AUD | 96.27% |
| Dimerix Limited | 583.47 Thousand AUD | -1872.082% |
| PharmAust Limited | -1641.00 AUD | 701298.355% |
| AnteoTech Limited | 460.39 Thousand AUD | -2399.292% |
| Paradigm Biopharmaceuticals Limited | 56.81 Thousand AUD | -20153.934% |
| Recce Pharmaceuticals Ltd | -366.76 Thousand AUD | 3237.314% |
| Avecho Biotechnology Limited | -43.79 Thousand AUD | 26373.924% |
| Actinogen Medical Limited | 9.93 Million AUD | -15.86% |
| Immuron Limited | 3.33 Million AUD | -244.842% |
| Argenica Therapeutics Limited | 2.59 Million AUD | -342.915% |